12.19USD+4.99%Mkt Cap: 175.52M USDP/E: —Last update: 2026-05-26
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United St…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap175.52M USD
Enterprise Value90.45M USD
Revenue (TTM)3.84M USD
Gross Profit-45.40M USD
Net Income (TTM)-117.26M USD
Revenue/Share0.3860 USD
Last Price12.19 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.21
PEG—
EV/EBITDA-1.14
EV/Revenue23.54
P/S42.04
P/B1.35
EPS (TTM)-11.68
EPS (Forward)-5.06
52W Range
5.20414% of range55.89
52W High55.89 USD
52W Low5.204 USD
Profitability
Gross Margin0.00%
Oper. Margin-2154.03%
EBITDA Margin0.00%
Profit Margin-1834.48%
ROE-227.96%
ROA-103.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-78.56M USD
CapEx (TTM)518.00K USD
FCF Margin-1016.09%
FCF Yield-22.24%
Net Debt-71.08M USD
Net Debt/EBITDA0.90
Balance Sheet
Debt/Equity0.85
Current Ratio8.13
Quick Ratio7.71
Book Value/Sh8.295 USD
Cash/Share7.902 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateNov 6, 2023
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)19.89 USD
Target Range8.000 USD – 30.00 USD
# Analysts9
Ownership
Shares Out.14.42M
Float9.36M
Insiders0.57%
Institutions100.63%
Short Interest
Short Ratio7.3d
Short % Float8.70%
Short % Out.7.75%
Shares Short1.12M
Short (prev mo.)1.06M
Technical
SMA 5012.28 (-0.7%)
SMA 20018.44 (-33.9%)
Beta2.23
S&P 52W Chg28.31%
Avg Vol (30d)106.87K
Avg Vol (10d)146.67K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—